↓ Skip to main content

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile…

Overview of attention for article published in Journal of Clinical Oncology, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
1 news outlet
twitter
16 X users
weibo
1 weibo user

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia
Published in
Journal of Clinical Oncology, April 2014
DOI 10.1200/jco.2013.51.6963
Pubmed ID
Authors

Giampaolo Bucaneve, Alessandra Micozzi, Marco Picardi, Stelvio Ballanti, Nicola Cascavilla, Prassede Salutari, Giorgina Specchia, Rosa Fanci, Mario Luppi, Laura Cudillo, Renato Cantaffa, Giuseppe Milone, Monica Bocchia, Giovanni Martinelli, Massimo Offidani, Anna Chierichini, Francesco Fabbiano, Giovanni Quarta, Valeria Primon, Bruno Martino, Annunziata Manna, Eliana Zuffa, Antonella Ferrari, Giuseppe Gentile, Robin Foà, Albano Del Favero

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United States 1 1%
Brazil 1 1%
Unknown 83 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 21%
Student > Doctoral Student 8 9%
Student > Ph. D. Student 7 8%
Other 6 7%
Student > Bachelor 6 7%
Other 23 27%
Unknown 18 21%
Readers by discipline Count As %
Medicine and Dentistry 48 56%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Biochemistry, Genetics and Molecular Biology 4 5%
Environmental Science 2 2%
Immunology and Microbiology 2 2%
Other 3 3%
Unknown 23 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2022.
All research outputs
#1,824,315
of 25,374,647 outputs
Outputs from Journal of Clinical Oncology
#4,432
of 22,046 outputs
Outputs of similar age
#18,029
of 240,573 outputs
Outputs of similar age from Journal of Clinical Oncology
#60
of 295 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,046 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 295 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.